000 | 02039nam a2200457 i 4500 | ||
---|---|---|---|
001 | EBC4768336 | ||
003 | MiAaPQ | ||
005 | 20240121104342.0 | ||
006 | m o d | | ||
007 | cr cnu|||||||| | ||
008 | 161223t20162016ts a ob 001 0 eng d | ||
020 | _z9781681082486 | ||
020 | _a9781681082479 (e-book) | ||
035 | _a(MiAaPQ)EBC4768336 | ||
035 | _a(Au-PeEL)EBL4768336 | ||
035 | _a(CaPaEBR)ebr11316550 | ||
035 | _a(OCoLC)966464117 | ||
040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
050 | 4 |
_aRC660 _b.F766 2016 |
|
082 | 0 |
_a616.462 _223 |
|
245 | 0 | 0 |
_aFrontiers in clinical drug research -- diabetes and obesity. _nVolume 3 / _ceditor, Atta-ur-Rahman, FRS. |
264 | 1 |
_aSharjah, United Arab Emirates : _bBentham Books, _c2016. |
|
264 | 4 | _c2016 | |
300 |
_a1 online resource (257 pages) : _billustrations, tables. |
||
336 |
_atext _2rdacontent |
||
337 |
_acomputer _2rdamedia |
||
338 |
_aonline resource _2rdacarrier |
||
490 | 0 |
_aFrontiers in Clinical Drug Research -- Diabetes and Obesity, _x2352-3220 ; _vVolume 3 |
|
504 | _aIncludes bibliographical references at the end of each chapters and index. | ||
588 | _aDescription based on online resource; title from PDF title page (Ebrary, viewed December 23, 2016). | ||
590 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
650 | 0 | _aDiabetes. | |
650 | 0 |
_aDiabetes _xAlternative treatment. |
|
650 | 0 | _aObesity. | |
650 | 0 |
_aObesity _vCongresses. |
|
655 | 4 | _aElectronic books. | |
700 | 0 |
_aAtta-ur-Rahman, _eeditor. |
|
776 | 0 | 8 |
_iPrint version: _tFrontiers in clinical drug research -- diabetes and obesity. Volume 3. _dSharjah, United Arab Emirates : Bentham Books, c2016 _hi, 248 pages _kFrontiers in Clinical Drug Research -- Diabetes and Obesity ; Volume 3 _z9781681082486 |
797 | 2 | _aProQuest (Firm) | |
856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=4768336 _zClick to View |
999 |
_c277653 _d277653 |